Original Query: ALL
Previous Study | Return to List | Next Study

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation (LIN-MD-63)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02559817
Recruitment Status : Recruiting
First Posted : September 24, 2015
Last Update Posted : February 26, 2018
Ironwood Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Forest Laboratories

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 18, 2020
  Estimated Study Completion Date : October 18, 2020